로딩 중…
지수 로딩 중…
Codexis, Inc.
CDXS· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$1.45+3.57%
2026-08-03
Financials
Valuation Metrics
Codexis, Inc.'s Market Cap is $132M. At end of 2025 it was $147M. Ranked #3064 of 3,111 in US market (top 98%), #1404 of 1,445 on NASDAQ (top 97%), #265 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 99%) by Market Cap.
Investment Metrics(as of 2026-08-03)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $132M | US#3,064/3,111 Sec#265/269 |
| Revenue | $78M | US#2,829/3,111 Sec#138/269 |
| Net Income | $-32M | US—/3,111 Sec—/269 |
| Total Assets | $129M | US#3,030/3,111 Sec#262/269 |
| Net Assets | $43M | US#2,951/3,111 Sec#244/269 |
| Value | ||
| P/B | 3.05x | US#1,671/3,111 Sec#88/269 |
| P/S | 1.69x | US#1,056/3,111 Sec#22/269 |
| FCF Yield | -16.78% | US—/3,111 Sec—/269 |
| Profitability | ||
| ROE | -73.99% | US#2,821/3,111 Sec#210/269 |
| ROA | -24.73% | US#2,835/3,111 Sec#146/269 |
| Op. Margin | -33.15% | US#2,743/3,111 Sec#109/269 |
| Revenue Growth | 102.15% | US#140/3,111 Sec#32/269 |
| Financial Health | ||
| Debt Ratio | 199.23% | US#1,793/3,111 Sec#204/269 |
| Total Debt | $73M | US#2,496/3,111 Sec#137/269 |
| FCF | $-22M | US#2,388/3,111 Sec#95/269 |
| Cash | $37M | US#2,710/3,111 Sec#244/269 |
| Current Ratio | 5.36x | US#441/3,111 Sec#139/269 |
| Performance | ||
| 1Y Return | -46.10% | US#2,934/3,111 Sec#241/269 |
| 1M Return | -41.30% | US#3,089/3,111 Sec#266/269 |
| From 52W High | -62.53% | US#2,953/3,111 Sec#245/269 |
| 1Y MDD | -70.57% | US#2,926/3,111 Sec#245/269 |
| Trading | ||
| Volume | 799,401 shares | US#1,330/3,111 Sec#129/269 |
| Trading Value | $1M | US#2,938/3,111 Sec#247/269 |
| Per Share | ||
| EPS | $-0.49 | US—/3,111 Sec—/269 |
| BPS | $0.56 | US#2,682/3,111 Sec#217/269 |